Mirova’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $216K | Sell |
4,675
-10,130
| -68% | -$469K | 0.03% | 111 |
|
|
2025
Q1 | $903K | Buy |
+14,805
| New | +$903K | 0.16% | 80 |
|
|
2024
Q2 | – | Sell |
-4,452
| Closed | -$241K | – | 128 |
|
|
2024
Q1 | $241K | Hold |
4,452
| – | – | 0.04% | 102 |
|
|
2023
Q4 | $228K | Sell |
4,452
-272
| -6% | -$14K | 0.05% | 79 |
|
|
2023
Q3 | $274K | Sell |
4,724
-7,529
| -61% | -$437K | 0.06% | 77 |
|
|
2023
Q2 | $784K | Sell |
12,253
-13,030
| -52% | -$833K | 0.14% | 72 |
|
|
2023
Q1 | $1.75M | Sell |
25,283
-20,304
| -45% | -$1.41M | 0.25% | 65 |
|
|
2022
Q4 | $3.28M | Buy |
45,587
+10,854
| +31% | +$781K | 0.51% | 39 |
|
|
2022
Q3 | $2.47M | Sell |
34,733
-15,435
| -31% | -$1.1M | 0.42% | 41 |
|
|
2022
Q2 | $3.86M | Sell |
50,168
-11,214
| -18% | -$863K | 0.55% | 30 |
|
|
2022
Q1 | $4.48M | Sell |
61,382
-1,391
| -2% | -$102K | 0.6% | 25 |
|
|
2021
Q4 | $3.91M | Buy |
62,773
+48,296
| +334% | +$3.01M | 0.47% | 29 |
|
|
2021
Q3 | $856K | Buy |
14,477
+1,327
| +10% | +$78.5K | 0.11% | 97 |
|
|
2021
Q2 | $878K | Buy |
13,150
+844
| +7% | +$56.4K | 0.11% | 81 |
|
|
2021
Q1 | $776K | Buy |
12,306
+1,673
| +16% | +$105K | 0.09% | 84 |
|
|
2020
Q4 | $659K | Buy |
10,633
+8,644
| +435% | +$536K | 0.08% | 80 |
|
|
2020
Q3 | $120K | Sell |
1,989
-676
| -25% | -$40.8K | 0.02% | 86 |
|
|
2020
Q2 | $157K | Sell |
2,665
-59
| -2% | -$3.48K | 0.04% | 69 |
|
|
2020
Q1 | $152K | Sell |
2,724
-1,192
| -30% | -$66.5K | 0.06% | 65 |
|
|
2019
Q4 | $251K | Buy |
3,916
+1,898
| +94% | +$122K | 0.09% | 72 |
|
|
2019
Q3 | $102K | Buy |
2,018
+183
| +10% | +$9.25K | 0.01% | 94 |
|
|
2019
Q2 | $83K | Buy |
+1,835
| New | +$83K | 0.01% | 94 |
|